| Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B | |
| Zhou, Pu; Dong, Minhui; Wang, Jinyu; Li, Fahong; Zhang, Jiming; Gu, Jingwen | |
| 刊名 | EXPERIMENTAL AND THERAPEUTIC MEDICINE
 |
| 2018 | |
| 卷号 | 16期号:5 |
| 关键词 | microRNA-125b hepatitis B virus nucleos(t)ide analogues treatment response |
| ISSN号 | 1792-0981 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3601629 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Zhou, Pu,Dong, Minhui,Wang, Jinyu,et al. Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B[J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE,2018,16(5). |
| APA | Zhou, Pu,Dong, Minhui,Wang, Jinyu,Li, Fahong,Zhang, Jiming,&Gu, Jingwen.(2018).Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B.EXPERIMENTAL AND THERAPEUTIC MEDICINE,16(5). |
| MLA | Zhou, Pu,et al."Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B".EXPERIMENTAL AND THERAPEUTIC MEDICINE 16.5(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论